NSC |
Compound |
Enrichment |
Correlation |
NSC 714604 |
Purpureagitosid |
0.0385613993886001 |
0.24108286 |
NSC 721049 |
7Z-Plakortide H |
0.0385613993886001 |
0.27476762 |
NSC 722854 |
1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline |
0.0385613993886001 |
0.38160802 |
NSC 723548 |
Null |
0.0385613993886001 |
0.21116395 |
NSC 723732 |
8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one |
0.0385613993886001 |
0.29706119 |
NSC 728035 |
1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di |
0.0385613993886001 |
0.2597538 |
NSC 728038 |
2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline |
0.0385613993886001 |
0.33838587 |
NSC 728316 |
6-(3-Piperazinyl-1-propyl)-5,6-dihydro-2,3-dimethoxy-8,9-met hylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline Dihydrochloride |
0.0385613993886001 |
0.28816264 |
NSC 730868 |
(+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one |
0.0385613993886001 |
0.14420892 |
NSC 732178 |
Null |
0.0385613993886001 |
0.01517425 |